RO.SW Stock — Price, Charts & Analysis

Roche Holding AG (RO.SW) has a trailing P/E of 24.51x and a forward P/E of 17.14x. This places RO.SW in a moderate earnings multiple territory based on the valuation data currently available on Worldtickers.

RO.SW trades with 24.51x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether RO.SW looks overvalued or undervalued.

RO.SW's P/E of 24.51x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

RO.SW's trailing EPS is CHF 15.34 and forward EPS is CHF 21.94. Reported earnings growth is -7.70%, which helps show current profit momentum.

EPS, or earnings per share, shows how much profit Roche Holding AG generated for each share. RO.SW's trailing EPS is CHF 15.34, and investors usually prefer EPS that is positive and growing over time.

Roche Holding AG has a market cap of CHF 299.58B, making RO.SW a large-cap stock based on the current market value shown on Worldtickers.

RO.SW's latest stock price on Worldtickers is CHF 376.00. The latest move is CHF 3.60 or 0.97%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

RO.SW's quote includes a latest price of CHF 376.00. The market open is CHF 374.80. Previous close is CHF 372.40. The intraday range is CHF 373.00 to CHF 377.40.

RO.SW is up in the latest quote, with a move of CHF 3.60 or 0.97%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

RO.SW generated CHF 62.96B in trailing revenue. Revenue growth is -1.20%, which helps show whether demand is expanding or slowing.

RO.SW's revenue growth is -1.20%, which is a negative demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

Yes, RO.SW shows positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is CHF 12.34B.

Gross margin is 74.17%. Margins show how efficiently Roche Holding AG turns revenue into profit.

Roche Holding AG carries CHF 33.31B and holds CHF 9.73B in cash.

RO.SW holds CHF 9.73B on its balance sheet.

RO.SW's book value per share is CHF 41.03.

Yes, Roche Holding AG pays a dividend of CHF 9.80 per share annually. The dividend yield is 263.00%. The payout ratio is 63.93%.

RO.SW's dividend yield is 263.00%. Its payout ratio is 63.93%, which helps judge dividend sustainability. Dividend investors usually prefer a reasonable yield, consistent cash flow, and a payout ratio that leaves room for reinvestment.

Worldtickers does not currently show a confirmed next ex-dividend date for RO.SW. The page does show dividend rate and yield when available, and investors should confirm record and payment dates through Roche Holding AG's investor relations materials.

RO.SW's five-year average dividend yield is 306.00%. Use this alongside current yield, payout ratio, and cash flow to understand whether today's dividend looks high or low versus recent history.

Institutions hold 10.94% of RO.SW shares. Insiders hold 72.31% of shares. Ownership mix helps investors understand how much of Roche Holding AG is held by professional investors and company insiders.

RO.SW has 106.69M shares outstanding. Float shares are 654.09M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for RO.SW, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for RO.SW is CHF 21.94. Earnings growth is -7.70%. Revenue growth is -1.20%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

RO.SW's trailing EPS is CHF 15.34. Forward EPS is CHF 21.94. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

RO.SW is in the Healthcare sector. Its earnings multiple is 24.51x. Its latest displayed growth metric is -1.20%. Compare these figures with sector peers before deciding whether Roche Holding AG is stronger or weaker than average.

RO.SW trades at CHF 376.00. The stock trades at 24.51x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Roche Holding AG's fundamentals.

RO.SW risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is 0.35, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

RO.SW should be compared with companies in Drug Manufacturers - General. Its earnings multiple is 24.51x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Roche Holding AG (RO.SW) operates in Healthcare, specifically Drug Manufacturers - General. Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19,

RO.SW trades on Swiss. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

RO.SW stock is priced in CHF on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Roche Holding AG's official website listed on Worldtickers is www.roche.com. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Roche Holding AG is headquartered in Basel, Switzerland. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

RO.SW is in the Healthcare sector and the Drug Manufacturers - General industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

RO.SW has traded between CHF 264.60 and CHF 383.00 over the past 52 weeks. At CHF 376.00, it is 1.83% below the high and 42.10% above the low. The 52-week range helps gauge long-term price momentum.

RO.SW is above both its 50-day and 200-day moving averages, which is a common uptrend signal. Its 50-day moving average is CHF 348.02 and its 200-day moving average is CHF 332.22.

RO.SW's RSI is 60.86. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

RO.SW's latest RSI reading is 60.86, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for RO.SW is near CHF 332.20. Key resistance is near CHF 378.80. Breaks above resistance or below support can change the short-term technical setup.

RO.SW's nearest reported support level is CHF 332.20. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

RO.SW's nearest reported resistance level is CHF 378.80. A breakout above resistance can improve momentum, especially when volume confirms the move.

RO.SW trades about 26.01K shares daily on average. The latest displayed volume is 16.56K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

RO.SW's MACD is -0.95, which is a negative momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

RO.SW is above both its 50-day and 200-day moving averages, which is a common uptrend signal. RSI is 60.86 (neutral). MACD is bearish. Nearest support is around CHF 332.20. Resistance is around CHF 378.80. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is CHF 365.55 (1.87% from price). MA50 is CHF 348.02 (7.00% from price). MA200 is CHF 332.22 (12.09% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. RO.SW's MA20 is CHF 365.55. MA50 is CHF 348.02. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

RO.SW's pivot is near CHF 365.40. Support is near CHF 332.20. Resistance is near CHF 378.80. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for RO.SW is near CHF 357.95. These levels help define risk and possible follow-through zones after a breakout or breakdown.

RO.SW's Bollinger range is roughly CHF 348.29 to CHF 382.81. Band width is near 9.44%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

RO.SW's ATR-based typical daily range is about 1.94%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 16.56K shares. Average volume is about 26.01K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

RO.SW's all-time high shown on Worldtickers is CHF 439.20. Its all-time low is CHF 111.50. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

RO.SW has a beta of 0.35, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.